For the Inventor, By the Inventor

Enter inventor name

Needham, MA, United States of America

Robert T Peters

USPTO Granted Patents = 61 (Patent Applications = 43)

CIPO Patents = 9 (Patent Applications = 14)

EPO Patents = 31 (Patent Applications = 43)

Average Co-Inventor Count = 3.7

ph-index = 16

Forward Citations = 1,196(Granted Patents)

Forward Citations (Not Self Cited) = 914(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Atlanta, GA (US) (2006 - 2009)
W. Roxbury, MA (US) (2013)
Kingwood, TX (US) (2016 - 2020)
West Roxbury, MA (US) (2008 - 2022)
Needham, MA (US) (2014 - 2023)

Company Filing History:

Bioverativ Therapeutics Inc.

Syntonix Pharmaceuticals, Inc.

United Parcel Service of America, Inc.

Biogen Idec Hemophilia Inc.

5. 2 out of 1,780

Exxonmobil Research and Engineering Company

Biogen Hemophila Inc.

Biogen Hemophilia Inc.

8. 1 out of 250

Years Active: 2006-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Gene Therapy

Chimeric Proteins

Factor VIII

Factor IX

Polypeptides

Procoagulant Compounds

Immunoglobulin Hybrids

Hemophilia Treatment

Clotting Factors

Fusion Proteins

Nucleic Acid Molecules

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12364774 - Nucleic acid molecules and uses thereof for non-viral gene therapy (2025-07-22),

2. 12275970 - Optimized factor IX gene (2025-04-14),

3. 12186375 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2025-01-07),

4. 12168776 - Nucleic acid molecules and uses thereof (2024-12-17),

5. 11787851 - Optimized factor VIII gene (2023-10-17),

6. 11401322 - Immunoglobulin chimeric monomer-dimer hybrids (2022-08-02),

7. 11370827 - Chimeric factor VIII polypeptides and uses thereof (2022-06-28),

8. 11266720 - Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof (2022-03-08),

9. 11261437 - Procoagulant compounds (2022-03-01),

10. 11225650 - Methods of using FIX polypeptides (2022-01-18),

11. 11192936 - Factor VIII chimeric proteins and uses thereof (2021-12-07),

12. 11168316 - Chimeric clotting factors (2021-11-09),

13. 11168125 - Immunoglobulin chimeric monomer-dimer hybrids (2021-11-09),

14. 11091534 - Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof (2021-08-17),

15. 11008561 - Optimized factor IX gene (2021-05-18),

Title: The Inventor Robert T Peters: Pioneering Innovations in Needham

Introduction: Robert T Peters is a distinguished inventor based in Needham, Massachusetts, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert T Peters holds several patents in diverse areas, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Robert T Peters has consistently pushed the boundaries of innovation, with his inventions making a significant impact in industries such as technology, healthcare, and sustainability.

Collaborations: Robert T Peters has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Robert T Peters stands as a visionary inventor whose passion for innovation and dedication to creating meaningful change continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…